This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hartmann, A. Articles by Mast, H. Search for Related Content PubMed PubMed Citation Articles by Hartmann, A. Articles by Mast, H. Related Collections Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage Angioplasty and Stenting Aneurysm, AVM, hematoma

(Stroke. 2002;33:1816.)
© 2002 American Heart Association, Inc.

Original Contributions

Risk of Endovascular Treatment of Brain Arteriovenous Malformations

A. Hartmann, MD; J. Pile-Spellman, MD; C. Stapf, MD; R.R. Sciacca, EngScD; A. Faulstich, MS; J.P. Mohr, MD; H.C. Schumacher, MD H. Mast, MD

From the Stroke Center, Neurological Institute, New York Presbyterian Hospital, New York (A.H., C.S., R.R.S., J.P.M., H.C.S., H.M.); Department of Interventional Neuroradiology, Columbia University, College of Physicians and Surgeons, New York, NY (A.H., J.P.-S.); Stroke Unit, Department of Neurology, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Berlin, Germany (A.H., C.S.); and Schlaganfallzentrum Halle, Stroke Unit, Berufsgenossenschaftliche Kliniken, Bergmannstrost, Halle, Germany (A.F., H.C.S., H.M.).

Correspondence to Andreas Hartmann, MD, Stroke Unit, Neurologische Klinik, Universitätsklinikum Benjamin Franklin, Hindenburgdamm 30, 1200 Berlin, Germany. E-mail ahart{at}zedat.fu-berlin.de

Background and Purpose— Independently assessed data on frequency, severity, and determinants of neurological deficits after endovascular treatment of brain arteriovenous malformations (AVMs) are scarce.

Methods— From the prospective Columbia AVM Study Project, 233 consecutive patients with brain AVM receiving 1 endovascular treatments were analyzed. Neurological impairment was assessed by a neurologist using the Rankin Scale before and after completed endovascular therapy. Multivariate logistic regression models were used to identify demographic, clinical, and morphological predictors of treatment-related neurological deficits. The analysis included the components used in the Spetzler-Martin risk score for AVM surgery (AVM size, venous drainage pattern, and eloquence of AVM location).

Results— The 233 patients were treated with 545 endovascular procedures. Mean follow-up time was 9.6 months (SD, 18.1 months). Two hundred patients (86%) experienced no change in neurological status after treatment, and 33 patients (14%) showed treatment-related neurological deficits. Of the latter, 5 (2%) had persistent disabling deficits (Rankin score >2), and 2 (1%) died. Increasing patient age [odds ratio (OR), 1.04; 95% confidence interval (CI), 1.01 to 1.08], number of embolizations (OR, 1.41; 95% CI, 1.16 to 1.70), and absence of a pretreatment neurological deficit (OR, 4.55; 95% CI, 1.03 to 20.0) were associated with new neurological deficits. None of the morphological AVM characteristics tested predicted treatment complications.

Conclusions— From independent neurological assessment and prospective data collection, our findings suggest a low rate of disabling treatment complications in this center for endovascular brain AVM treatment. Risk predictors for endovascular treatment differ from those for AVM surgery.

Key Words: arteriovenous malformations • embolization, therapeutic • outcome

This article has been cited by other articles:

				M.V. Jayaraman, M.L. Marcellus, S. Hamilton, H.M. Do, D. Campbell, S.D. Chang, G.K. Steinberg, and M.P. Marks Neurologic Complications of Arteriovenous Malformation Embolization Using Liquid Embolic Agents AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 242 - 246. [Abstract] [Full Text] [PDF]

				D. R. Hadizadeh, M. von Falkenhausen, J. Gieseke, B. Meyer, H. Urbach, R. Hoogeveen, H. H. Schild, and W. A. Willinek Cerebral Arteriovenous Malformation: Spetzler-Martin Classification at Subsecond-Temporal-Resolution Four-dimensional MR Angiography Compared with That at DSA Radiology, December 1, 2007; 246(1): 205 - 213. [Abstract] [Full Text] [PDF]

				R. M. Friedlander Arteriovenous Malformations of the Brain N. Engl. J. Med., June 28, 2007; 356(26): 2704 - 2712. [Full Text] [PDF]

				M. Cronqvist, R. Wirestam, B. Ramgren, L. Brandt, B. Romner, O. Nilsson, H. Saveland, S. Holtas, and E.-M. Larsson Endovascular Treatment of Intracerebral Arteriovenous Malformations: Procedural Safety, Complications, and Results Evaluated by MR Imaging, Including Diffusion and Perfusion Imaging AJNR Am. J. Neuroradiol., January 1, 2006; 27(1): 162 - 176. [Abstract] [Full Text] [PDF]

				A. Hartmann, H. Mast, J. P. Mohr, J. Pile-Spellman, E. S. Connolly, R. R. Sciacca, A. Khaw, and C. Stapf Determinants of Staged Endovascular and Surgical Treatment Outcome of Brain Arteriovenous Malformations Stroke, November 1, 2005; 36(11): 2431 - 2435. [Abstract] [Full Text] [PDF]

				R Al-Shahi and C Warlow Arteriovenous malformations of the brain: ready to randomise? J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1327 - 1329. [Full Text] [PDF]

				J.P. Mohr Brain Arteriovenous Malformations: Children and Adults Stroke, October 1, 2005; 36(10): 2060 - 2061. [Full Text] [PDF]

				C. Stapf, A.V. Khaw, R.R. Sciacca, C. Hofmeister, H.C. Schumacher, J. Pile-Spellman, H. Mast, J.P. Mohr, and A. Hartmann Effect of Age on Clinical and Morphological Characteristics in Patients With Brain Arteriovenous Malformation Stroke, November 1, 2003; 34(11): 2664 - 2669. [Abstract] [Full Text] [PDF]

				D. M. Pelz Advances in Interventional Neuroradiology Stroke, February 1, 2003; 34(2): 357 - 358. [Full Text] [PDF]